Dry Eye Syndromes, Cataract
Conditions
Brief summary
This study will evaluate the effect of sodium carboxymethylcellulose eye drops in the treatment of dry eye after cataract surgery.
Interventions
Sodium carboxymethylcellulose (Refresh Liquigel®) 1 drop in the study eye 4 times a day for 30 days post-cataract surgery.
Levofloxacin 1 drop in the study eye 3 times a day for 7 days post-cataract surgery.
Prednisolone 1 drop in the study eye 4 times a day for the 1st week post surgery, 3 times a day for the 2nd week post surgery, 2 times a day for the 3rd week post surgery, and 1 time a day for the 4th week post surgery.
Sponsors
Study design
Eligibility
Inclusion criteria
* Diagnosis of age-related cataract in the study eye * Scheduled for cataract surgery and lens implant
Exclusion criteria
* Diagnosis of ocular surface disease or glaucoma * Ocular surgery in the past 3 months * Wearing a corneal contact lens in the study eye
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Tear Break-Up Time (TBUT) in the Study Eye | Day 7 | TBUT is the time required for dry spots to appear on the surface of the study eye after blinking. The longer it takes, the more stable the tear film. A short TBUT is a sign of poor tear film. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fluorescein Staining Score in the Study Eye | Day 7, Day 30 | The cornea is evaluated following ocular administration of fluorescein stain in the study eye. The cornea is the transparent front part of the eye which covers the iris and pupil. The cornea is divided into 3 regions. Each region is scored according to the extent of staining, with scores ranging from 0 to 3 points: 0=non-staining, 1=staining range \< 1/2 of the cornea, 2=staining range ≥ 1/2 of the cornea, and 3=regional whole staining of the cornea. The total score ranges from 0 to 9 points. The higher the staining score, the worse the dry eye condition. |
| Lissamine Green Staining Score in the Study Eye | Day 7, Day 30 | Conjunctival and corneal staining are evaluated following ocular administration of lissamine green dye in the study eye. The conjunctiva is the clear membrane covering the white surface of the eye. The cornea is the transparent front part of the eye which covers the iris and pupil. The conjunctiva and cornea are divided into 5 regions that are scored based on the extent of staining. Scores range from 0 to 3 points: 0=non-staining, 1=staining range \< 1/2 of the conjunctiva and cornea, 2=staining range ≥ 1/2 of the conjunctiva and cornea, and 3=regional whole staining of the conjunctiva and cornea. The total score ranges from 0 to 15 points. The higher the grade score, the worse the dry eye condition. |
| Results of Schirmer I Test With Anesthetics in the Study Eye | Day 7, Day 30 | The Schirmer I test consists of anesthetic drops being placed into the lower eyelid of the study eye. Patients then close their eyes. Test paper is placed on the lower eyelid of the patient's closed eyes. The paper is then removed and the moisture length on the paper recorded. Shorter distances indicate worse dry eye symptoms. |
| Ocular Surface Disease Index (OSDI) Questionnaire Score in the Study Eye | Day 7, Day 30 | The OSDI is a 12-question survey for patients to document their dry eye disease symptoms in the study eye. The OSDI consists of a 5-point scale (0=none of the time and 4 = all of the time), with higher scores representing greater disability. The scores are totaled over the 12 questions and converted to a score of 0-100 (0=no disability and 100=complete disability). |
| Subjective Symptom Total Score in the Study Eye | Day 7, Day 30 | The following 11 subjective symptoms are evaluated in the study eye: foreign body sensation, photophobia, itching, pain in the eye, dry eye, eye heaviness, blurred vision, eye fatigue, eye discomfort, eye secretions and tears. Each of these symptoms is divided into 4 classes: no symptom=0; occasional symptoms=1; intermittent mild symptoms=2; and persistent obvious symptoms=3. The total score ranged from 0 (best) to 33 (worst). |
Countries
China
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Sodium Carboxymethylcellulose and Conventional Therapy Sodium carboxymethylcellulose (Refresh Liquigel®) 1 drop in the study eye 4 times a day for 30 days plus conventional therapy of levofloxacin for 7 days post-cataract surgery and prednisolone for 30 days post-cataract surgery each in the study eye up to 4 times a day. | 90 |
| Conventional Therapy Conventional therapy of levofloxacin for 7 days post-cataract surgery and prednisolone for 30 days post-cataract surgery each in the study eye up to 4 times a day. | 90 |
| Total | 180 |
Baseline characteristics
| Characteristic | Sodium Carboxymethylcellulose and Conventional Therapy | Conventional Therapy | Total |
|---|---|---|---|
| Age, Continuous | 68.8 Years STANDARD_DEVIATION 7.1 | 69.0 Years STANDARD_DEVIATION 7.1 | 68.9 Years STANDARD_DEVIATION 7.1 |
| Sex: Female, Male Female | 54 Participants | 59 Participants | 113 Participants |
| Sex: Female, Male Male | 36 Participants | 31 Participants | 67 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 86 | 0 / 85 |
| serious Total, serious adverse events | 0 / 86 | 0 / 85 |
Outcome results
Tear Break-Up Time (TBUT) in the Study Eye
TBUT is the time required for dry spots to appear on the surface of the study eye after blinking. The longer it takes, the more stable the tear film. A short TBUT is a sign of poor tear film.
Time frame: Day 7
Population: All patients with data at this time point
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Sodium Carboxymethylcellulose and Conventional Therapy | Tear Break-Up Time (TBUT) in the Study Eye | 8.5 Seconds | Standard Deviation 5.5 |
| Conventional Therapy | Tear Break-Up Time (TBUT) in the Study Eye | 6.6 Seconds | Standard Deviation 3.8 |
Tear Break-Up Time (TBUT) in the Study Eye
TBUT is the time required for dry spots to appear on the surface of the study eye after blinking. The longer it takes, the more stable the tear film. A short TBUT is a sign of poor tear film.
Time frame: Day 30
Population: All patients with data at this time point
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Sodium Carboxymethylcellulose and Conventional Therapy | Tear Break-Up Time (TBUT) in the Study Eye | 9.0 Seconds | Standard Deviation 5.9 |
| Conventional Therapy | Tear Break-Up Time (TBUT) in the Study Eye | 6.7 Seconds | Standard Deviation 4.8 |
Fluorescein Staining Score in the Study Eye
The cornea is evaluated following ocular administration of fluorescein stain in the study eye. The cornea is the transparent front part of the eye which covers the iris and pupil. The cornea is divided into 3 regions. Each region is scored according to the extent of staining, with scores ranging from 0 to 3 points: 0=non-staining, 1=staining range \< 1/2 of the cornea, 2=staining range ≥ 1/2 of the cornea, and 3=regional whole staining of the cornea. The total score ranges from 0 to 9 points. The higher the staining score, the worse the dry eye condition.
Time frame: Day 7, Day 30
Population: All patients with data at this time point
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Sodium Carboxymethylcellulose and Conventional Therapy | Fluorescein Staining Score in the Study Eye | Day 7 | 2.0 Scores on a Scale | Standard Deviation 2.8 |
| Sodium Carboxymethylcellulose and Conventional Therapy | Fluorescein Staining Score in the Study Eye | Day 30 (N=83, 82) | 1.1 Scores on a Scale | Standard Deviation 1.8 |
| Conventional Therapy | Fluorescein Staining Score in the Study Eye | Day 7 | 1.8 Scores on a Scale | Standard Deviation 2.6 |
| Conventional Therapy | Fluorescein Staining Score in the Study Eye | Day 30 (N=83, 82) | 1.2 Scores on a Scale | Standard Deviation 1.9 |
Lissamine Green Staining Score in the Study Eye
Conjunctival and corneal staining are evaluated following ocular administration of lissamine green dye in the study eye. The conjunctiva is the clear membrane covering the white surface of the eye. The cornea is the transparent front part of the eye which covers the iris and pupil. The conjunctiva and cornea are divided into 5 regions that are scored based on the extent of staining. Scores range from 0 to 3 points: 0=non-staining, 1=staining range \< 1/2 of the conjunctiva and cornea, 2=staining range ≥ 1/2 of the conjunctiva and cornea, and 3=regional whole staining of the conjunctiva and cornea. The total score ranges from 0 to 15 points. The higher the grade score, the worse the dry eye condition.
Time frame: Day 7, Day 30
Population: All patients with data at this time point
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Sodium Carboxymethylcellulose and Conventional Therapy | Lissamine Green Staining Score in the Study Eye | Day 7 | 2.9 Scores on a Scale | Standard Deviation 3.3 |
| Sodium Carboxymethylcellulose and Conventional Therapy | Lissamine Green Staining Score in the Study Eye | Day 30 (N=83,82) | 2.1 Scores on a Scale | Standard Deviation 2.4 |
| Conventional Therapy | Lissamine Green Staining Score in the Study Eye | Day 30 (N=83,82) | 2.3 Scores on a Scale | Standard Deviation 2.6 |
| Conventional Therapy | Lissamine Green Staining Score in the Study Eye | Day 7 | 2.6 Scores on a Scale | Standard Deviation 3.2 |
Ocular Surface Disease Index (OSDI) Questionnaire Score in the Study Eye
The OSDI is a 12-question survey for patients to document their dry eye disease symptoms in the study eye. The OSDI consists of a 5-point scale (0=none of the time and 4 = all of the time), with higher scores representing greater disability. The scores are totaled over the 12 questions and converted to a score of 0-100 (0=no disability and 100=complete disability).
Time frame: Day 7, Day 30
Population: All patients with data at this time point
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Sodium Carboxymethylcellulose and Conventional Therapy | Ocular Surface Disease Index (OSDI) Questionnaire Score in the Study Eye | Day 30 (N=83, 82) | 12.7 Scores on a Scale | Standard Deviation 11.3 |
| Sodium Carboxymethylcellulose and Conventional Therapy | Ocular Surface Disease Index (OSDI) Questionnaire Score in the Study Eye | Day 7 | 15.6 Scores on a Scale | Standard Deviation 16.8 |
| Conventional Therapy | Ocular Surface Disease Index (OSDI) Questionnaire Score in the Study Eye | Day 30 (N=83, 82) | 14.2 Scores on a Scale | Standard Deviation 13.8 |
| Conventional Therapy | Ocular Surface Disease Index (OSDI) Questionnaire Score in the Study Eye | Day 7 | 18.1 Scores on a Scale | Standard Deviation 19.5 |
Results of Schirmer I Test With Anesthetics in the Study Eye
The Schirmer I test consists of anesthetic drops being placed into the lower eyelid of the study eye. Patients then close their eyes. Test paper is placed on the lower eyelid of the patient's closed eyes. The paper is then removed and the moisture length on the paper recorded. Shorter distances indicate worse dry eye symptoms.
Time frame: Day 7, Day 30
Population: All patients with data at this time point
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Sodium Carboxymethylcellulose and Conventional Therapy | Results of Schirmer I Test With Anesthetics in the Study Eye | Day 30 (N=83, 82) | 12.7 Millimeters | Standard Deviation 6.1 |
| Sodium Carboxymethylcellulose and Conventional Therapy | Results of Schirmer I Test With Anesthetics in the Study Eye | Day 7 | 11.8 Millimeters | Standard Deviation 5.6 |
| Conventional Therapy | Results of Schirmer I Test With Anesthetics in the Study Eye | Day 7 | 12.5 Millimeters | Standard Deviation 6.8 |
| Conventional Therapy | Results of Schirmer I Test With Anesthetics in the Study Eye | Day 30 (N=83, 82) | 12.6 Millimeters | Standard Deviation 6.5 |
Subjective Symptom Total Score in the Study Eye
The following 11 subjective symptoms are evaluated in the study eye: foreign body sensation, photophobia, itching, pain in the eye, dry eye, eye heaviness, blurred vision, eye fatigue, eye discomfort, eye secretions and tears. Each of these symptoms is divided into 4 classes: no symptom=0; occasional symptoms=1; intermittent mild symptoms=2; and persistent obvious symptoms=3. The total score ranged from 0 (best) to 33 (worst).
Time frame: Day 7, Day 30
Population: All patients with data at this time point
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Sodium Carboxymethylcellulose and Conventional Therapy | Subjective Symptom Total Score in the Study Eye | Day 7 | 6.1 Scores on a Scale | Standard Deviation 5.3 |
| Sodium Carboxymethylcellulose and Conventional Therapy | Subjective Symptom Total Score in the Study Eye | Day 30 (N=83, 82) | 5.1 Scores on a Scale | Standard Deviation 3.6 |
| Conventional Therapy | Subjective Symptom Total Score in the Study Eye | Day 7 | 6.4 Scores on a Scale | Standard Deviation 5.2 |
| Conventional Therapy | Subjective Symptom Total Score in the Study Eye | Day 30 (N=83, 82) | 5.6 Scores on a Scale | Standard Deviation 4 |